Compound Profile: TURINABOL PHARMA GROUP CO
Turinabol from Pharma Group Co is a chlorinated derivative of metandienone, classified as an anabolic androgenic steroid modified with a 4-chloro substitution. This structural modification alters its binding characteristics at androgen receptors while reducing its aromatisation potential in preclinical models. Researchers at Stroid UK Shop investigate this compound for its unique pharmacokinetic properties and tissue-selective androgenic activity in vitro studies. The chlorinated structure provides distinct metabolic pathways compared to non-halogenated analogues, making it valuable for comparative steroid research protocols.
Laboratory Applications
This compound serves as an essential reference standard for studying anabolic steroid mechanisms in cellular research environments. Scientists examine its effects on protein synthesis pathways, nitrogen retention markers, and receptor binding affinity studies. Research teams focusing on turinabol oral steroids utilise this compound to investigate hepatic metabolism patterns and enzymatic interactions. The oral bioavailability characteristics make it particularly suitable for absorption and distribution studies in laboratory settings, complementing broader research programs involving SARMs and peptides for comparative pharmacological analysis.
Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 4-Chlorodehydromethyltestosterone |
| CAS Number | 2446-23-3 |
| Molecular Formula | C₂₀H₂₇ClO₂ |
| Molecular Weight | 334.88 g/mol |
| Form | Oral tablets |
| Storage | Room temperature, dry conditions |
Research Use Only
This product is manufactured exclusively for in-vitro research applications and laboratory studies. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with all applicable regulations governing research chemical handling and disposal.
